INSUBCONTINENT EXCLUSIVE:
Virtual Incision Corporation has also had a pretty solid fundraising streak since its 2006 founding
startup announced its latest funding round
The $20 million Series B+ brings its total funding up to $51 million
Among is biggest value propositions is the relative portability of the product, versus many existing surgery robots, which are downright
Investigational Device Exemption (IDE) with the FDA
VIC will also use it to help get the device ready for commercialization.
